Who founded Motif Neurotech?

Motif Neurotech was founded by Sameer Sheth, Sunil Sheth in 2022.

Who are Motif Neurotech's investors?

Motif Neurotech's investors include Arboretum Ventures, Divergent Capital, Dolby Family Ventures, Features Capital Holdings, PsyMed Ventures, TMC Venture Fund, XEIA Venture Partners, Capital Factory and 5 more.

How much funding has Motif Neurotech raised?

Motif Neurotech has disclosed $15.3M raised across 1 round.

Where is Motif Neurotech headquartered?

Motif Neurotech is headquartered in Houston, US.

Motif Neurotech

Houston, US · Founded 2022 · Delaware corporation · 15 known investors

Find your way into Motif Neurotech

Paths you didn't know you had: your email and LinkedIn already hold routes to the Motif Neurotech team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression. The company builds implantable neurotechnology for patients with mental illness and is based in Houston, Texas.

Biotech Deep Tech Digital Health Healthtech Medical Devices

Founders & leadership

Motif Neurotech was founded in 2022 by Sameer Sheth and Sunil Sheth.

Sameer ShethFounder

Sunil ShethFounder

Nick Halper Chief Operating OfficerNick Halper is Chief Operating Officer at Motif Neurotech, a Houston-based company developing implantable brain-computer interfaces to treat severe mental health conditions. He has experience building operational systems and processes for complex deep-tech and medical device projects.

Steve Goetz Chief Technology OfficerSteve Goetz is Chief Technology Officer at Motif Neurotech, where he leads the design and development of neuromodulation systems. He has extensive experience in medical device engineering, including work on brain and nerve interfaces, implantable stimulators, and infusion systems, as well as expertise in R&D strategy, product pipeline management, and cross-functional team leadership.

Anthony Arnold Executive AdvisorCEO at Sensydia

Kaiyuan YangFounder

Board

Jacob Robinson FounderAdvisor at PsyMed Ventures

Thomas M. ShehabBoard director

Amy Kruse Board directorVenture Partner at Prime Movers Lab

Investors · 15

Arboretum Ventureslisted by Arboretum VenturesAnn Arbor · $5M – $15M

How we know: Arboretum Ventures's portfolio page · mpo-mag.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Divergent Capitallisted by Divergent CapitalNew York · $250K – $1M

How we know: Divergent Capital's portfolio page · mpo-mag.com · open dataset · 5k.vc investor directory · Not right? Tell us

Dolby Family Ventureslisted by Dolby Family VenturesSan Francisco

How we know: Dolby Family Ventures's portfolio page · funding news · mpo-mag.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Features Capital Holdingslisted by Features Capital HoldingsLebanon

How we know: Features Capital Holdings's portfolio page · Not right? Tell us

PsyMed Ventureslisted by PsyMed VenturesBerkeley

How we know: PsyMed Ventures's portfolio page · mpo-mag.com · Not right? Tell us

TMC Venture Fundlisted by TMC Venture FundHouston

How we know: TMC Venture Fund's portfolio page · Not right? Tell us

XEIA Venture Partnerslisted by XEIA Venture PartnersSan Francisco

Capital FactoryreportedAustin

How we know: mpo-mag.com · Not right? Tell us

Empath VenturesreportedSan Francisco

How we know: mpo-mag.com · open dataset · 5k.vc investor directory · Not right? Tell us

Interface FundreportedSan Francisco · $1M – $10M

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

KdT VenturesreportedAustin · $500K – $3M

How we know: mpo-mag.com · Not right? Tell us

Prime Movers LabreportedJackson · $2M – $30Mvia Amy Kruse · board

How we know: a partner's Signal profile · board seat on SEC Form D · Not right? Tell us

re.Mind CapitalreportedLondon

How we know: mpo-mag.com · Not right? Tell us

Also in the syndicate · 2

Satori NeuroTMC Innovation

Reported raises · per SEC filings

Form D private placements

$15.3M disclosed across 1 round · 2024

▶$15.3MraisedJan 2024 · 28 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Anthony ArnoldDirector
Jacob RobinsonExecutive Officer, Director
Thomas M. ShehabDirector
Amy KruseDirector

Offering amount: $21.6M
Amount sold: $15.3M
First sale: Jan 2024
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Motif Neurotech went on to found or lead other companies.

Anthony ArnoldDirectorFounded Sensydia +1 Jacob RobinsonFounderFounded VO Health

Related companies · 7

Blackrock NeurotechBlackrock Neurotech develops a neurotechnology platform, including brain-computer interface systems, aimed at improving patient lives and treating neurological conditions. It builds implantable neural interface technology for medical and research applications.

Neuralink-LogoArtboard-1Neurotechnology company developing implantable brain-computer interfaces for people with paralysis and vision loss.

Precision NeurosciencePrecision Neuroscience develops a minimally invasive, high-bandwidth brain-computer interface, including its Layer 7 cortical interface, initially aimed at helping people with paralysis control digital devices and robotics using their thoughts. The company works with hospital clinical partners on implanted studies and positions its technology as removable and upgradable without damaging the brain.

NeuroelectricsNeuroelectrics develops the Starstim platform, combining EEG monitoring headpieces, cloud-based delivery, and personalized protocols to deliver non-invasive Transcranial Electrical Stimulation (tES) neuromodulation therapy for brain disorders such as depression and epilepsy. It serves patients whose conditions are not controlled by drugs or surgery, as well as neuroscience researchers who use its tools for brain research.

SynchronSynchron develops brain-computer interface technology delivered via catheter to restore or improve motor and cognitive function in people with impairment or decline. The company serves patients with motor impairment and cognitive decline using a minimally invasive approach inspired by cardiac interventional procedures.

Pano AIPano develops artificial intelligence and machine learning technology solutions to help utility companies and fire agencies detect and manage wildfire threats. The company serves emergency managers and professionals in the utility and fire industries seeking to protect communities from wildfires.

ParadromicsParadromics develops a brain-computer interface (BCI) system, with FDA Breakthrough Device Designations for speech decoding and digital device control, and works with academic medical institutions on translational BCI research. The company builds implantable neurotechnology aimed at clinical applications.

Companies working in the same space as Motif Neurotech.

In the news

Motif Neurotech Raises $18.75M in Series A Fundingfinsmes.com · Jan 2024

Frequently asked questions

What does Motif Neurotech do?: Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression. The company builds implantable neurotechnology for patients with mental illness and is based in Houston, Texas.
Who founded Motif Neurotech?: Motif Neurotech was founded by Sameer Sheth, Sunil Sheth in 2022.
Who are Motif Neurotech's investors?: Motif Neurotech's investors include Arboretum Ventures, Divergent Capital, Dolby Family Ventures, Features Capital Holdings, PsyMed Ventures, TMC Venture Fund, XEIA Venture Partners, Capital Factory and 5 more.
How much funding has Motif Neurotech raised?: Motif Neurotech has disclosed $15.3M raised across 1 round.
Where is Motif Neurotech headquartered?: Motif Neurotech is headquartered in Houston, US.